Effects of montelukast and beclomethasone on airway function and asthma control

Journal of Allergy and Clinical Immunology

Volumn 110, Issue 6, 2002, Pages 847-854

  Israel, Elliot ^a   Chervinsky, Paul S ^b   Friedman, Bruce ^c   Van Bavel, Julius ^d   Skalky, Carol S ^e   Ghannam, Asma F ^e   Bird, Steven R ^e   Edelman, Jonathan M ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b New England Research Center Inc   (United States)

^c A A B/Immunol Ass Med Grp   (United States)

^d Allergy and Asthma Associates   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Asthma; Beclomethasone; Montelukast

Indexed keywords

BECLOMETASONE; MONTELUKAST; PLACEBO; SALBUTAMOL;

ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUSITIS; UPPER RESPIRATORY TRACT INFECTION;

EID: 0036907604     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.129413     Document Type: Article

References (29)

1. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Md: National Institutes of Health; 1997. p. 57-79.
2. Kelloway JS, Wyatt RA, Adlis SA. Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Arch Intern Med 1994;154:1349-52.
3. Ringdal N, Whitney JG, Summerton L. Problems with inhaler technique and patient preference for oral therapy: Tablet zafirlukast vs. inhaled beclomethasone [abstract]. Am J Respir Crit Care Med 1998;157:A416.
4. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol 1996;98:1051-7.
5. Reiss TF, Chervinsky P, Dockhom RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213-20.
6. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999;160:1862-8.
7. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: A randomized, controlled trial. Ann Intern Med 1999;130:487-95.
8. Edelman JM, Milewski KA, Turpin JA, Santanello NC, Bird SR, Rader CR. Effectiveness and safety of montelukast, a leukotriene receptor antagonist, compared to inhaled cromolyn in moderate asthmatic children ages 6 to 11 [abstract]. J Allergy Clin Immunol 1999;103:S134.
9. Volovitz B, Duenas-Meza E, Chmielewska-Szewczyk D, Kosa L, Astafieva NG, Villaran C, et al. Comparison of oral montelukast and inhaled cromolyn with respect to preference, satisfaction, and adherence: A multicenter, randomized, open-label, crossover study in children with mild to moderate persistent asthma. Curr Ther Res 2000;61:490-507.
10. Drazen JM, Boccuzzi SJ, Wogen J, Strub P, Jones C, Nelsen L, et al. Adherence to prescribed treatment for asthma [abstract]. Am J Respir Crit Care Med 2000;161:A402.
11. Sculpher MJ, Buxton MJ. The episode-free day as a composite measure of effectiveness. An illustrative economic evaluation of formoterol versus salbutamol in asthma therapy. Pharmacoeconomics 1993;4:345-52.
12. Santanello NC, Zhang J, Seidenberg B, Reiss TF, Barber BL. What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 1999;14:23-7.
13. Bukstein DA. Practical approach to the use of outcomes in asthma. Traveling the road to better asthmatic care. Immunol Allergy Clin North Am 1996;16:859-91.
14. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J 1997;10:646-51.
15. American Thoracic Society. Standardization of spirometry 1994 update. Am J Respir Crit Care Med 1995;152:1107-36.
16. Selvin S. Statistical Analysis of Epidemiologie Data. New York: Oxford University Press; 1991.
17. Gastwirth JL. Statistical measures of earnings differentials. Am Statistician 1975;29:32-5.
18. Stine RA, Heyse JF. Nonparametric estimates of overlap. Stat Med 2001;20:215-36.
19. Snedecor GW, Cochran WG. Statistical Methods. 8th Ed. Ames, Iowa: Iowa State University Press; 1989.
20. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention: A Pocket Guide for Physicians and Nurses. Bethesda, Md: National Institutes of Health; 1998.
21. Rutten-Van Molken MPMH, Van Doorslaer EKA, Jansen MCC, Van Essen-Zandvliet EE, Rutten FFH. Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilatory monotherapy in children with asthma. Pharmacoeconomics 1993;4:257-70.
22. Teeter JG, Bleecker ER. Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest 1998;113:272-7.
23. Drazen JM, O'Brien J, Sparrow D, Weiss ST, Martins MA, Israel E, et al. Recovery of leukotriene E4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992;146:104-8.
24. Busse W, Raphael GD, Galant S, Kalberg C, Goode-Sellers S, Srebro S, et al. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial. J Allergy Clin Immunol 2001;107:461-8.
25. Kamada AK, Szefler SJ, Martin RJ, Boushey HA, Chinchilli VM, Drazen JM, et al. Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 1996;153:1739-48.
26. Chervinsky P, van As A, Bronsky EA, Dockhorn R, Noonan M, LaForce C, et al. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. J Allergy Clin Immunol 1994;94:676-83.
27. Nash DB, Sullivan SD, Mackowiak J. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting. Am J Managed Care 2000;6:S3-15.
28. Wagner JS. Inhaled steroids in children: Risks versus rewards. J Pediatr 1998;132:381-3.
29. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, Leboff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001;345:941-7.